Springer Nature OAopen access
Analysis of adverse event reporting with casimersen: a pharmacovigilance study based on the United States food and drug administration adverse event reporting system database
Medicine & Public Health, Internal Medicine, Pharmacy
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Record · ID 182800
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.